K-S. Lee

发表

Interventions do not enhance medication persistence and compliance in patients with overactive bladder: a 24 weeks, randomised, open‐label, multi‐center trial

Tae Heon Kim, D. Han, H. Sung, 2015, International journal of clinical practice.

Persistence with solifenacin add‐on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy

B. H. Chung, B. Chung, C. Kim, 2014, International journal of clinical practice.

Symptom change after discontinuation of successful antimuscarinic treatment in patients with overactive bladder symptoms: a randomised, multicentre trial

J. Y. Lee, Seung-June Oh, Youngpo Lee, 2011, International journal of clinical practice.

A randomised, prospective double‐blind, propiverine‐controlled trial of imidafenacin in patients with overactive bladder

J. Park, Juryun Kim, J. Seo, 2014, International journal of clinical practice.

A randomised, double‐blind, parallel design, multi‐institutional, non‐inferiority phase IV trial of imidafenacin versus fesoterodine for overactive bladder

H. G. Kim, J. Kim, J. Seo, 2013, International journal of clinical practice.

Persistence of solifenacin therapy in patients with overactive bladder in the clinical setting: a prospective, multicenter, observational study

M. Choo, K-S. Lee, J. Lee, 2016, International journal of clinical practice.

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study

J. Paick, M. Choo, H. C. Jung, 2008, International journal of clinical practice.

Patient‐reported goal achievement after antimuscarinic treatment in patients with overactive bladder symptoms

J. Seo, M. Choo, Y.-S. Lee, 2012, International journal of clinical practice.

Prescription pattern of oxybutynin ER in patients with overactive bladder in real life practice: a multicentre, open‐label, prospective observational study

M. Choo, K-S. Lee, D. Yoo, 2012, International journal of clinical practice.

Sociocultural and environmental influences on bladder health

M. Palmer, M. Takeda, J. Wyndaele, 2012, International journal of clinical practice.

Rate and associated factors of solifenacin add‐on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms

B. H. Chung, H. Lee, C. Kim, 2015, International journal of clinical practice.

Satisfaction with tolterodine: assessing symptom‐specific patient‐reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study)

M. Choo, K-S. Lee, C. Doo, 2007, International journal of clinical practice.

154 Therapeutic effect of transurethral resection and coagulation of Hunner's lesion in interstitial cystitis/bladder pain syndrome patients

Juhyun Park, H. Sung, Seung Wook Lee, 2015 .

The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double‐blind, placebo‐controlled phase 2 study

M. Choo, S. W. Kim, S. Oh, 2015, International journal of clinical practice.